Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Phase II Study to Evaluate the Safety and Efficacy of the Oral Neurokinin-1 Receptor Antagonist Casopitant (GW679769) Administered With Ondansetron for the Prevention of Postoperative and Postdischarge Nausea and Vomiting in High-Risk Patients

doi: 10.1097/SA.0b013e31820eca68
Perioperative Complications
Buy
© 2011 Lippincott Williams & Wilkins, Inc.